fda compounding semaglutide news october 2025 Beyond the Headlines: Warning Letters to GLP-1 Compounders Semaglutide shortage ends as FDA

But what if the plateau stems not from what you're doing wrong, but from what you're not measuring

Gamma-glutamyl L-DOPA has been shown to increase organ-specific dopamine concentration in mouse models and is thus perceived a potential treatment for Parkinsons disease (Ichinose et al., 1987)

Using sterile water for multi-dose vials creates contamination risk

For a plain-English primer on why Tesamorelin specifically is studied for deep abdominal fat, see our overview of Tesamorelins visceral-fat benefits and safety

This has made retatrutide feel like one of the biggest whats next? names in medical weight loss right now

These effects are generally short-term and subside as the body adapts